Access the full text.
Sign up today, get DeepDyve free for 14 days.
M. Almeida, M. Cordero, J. Almeida, A. Órfão (2006)
Persistent Abnormalities in Peripheral Blood Dendritic Cells and Monocytes from HIV-1-Positive Patients After 1 Year of Antiretroviral TherapyJAIDS Journal of Acquired Immune Deficiency Syndromes, 41
L. Azzoni, J. Chehimi, Lan Zhou, A. Foulkes, Rayford June, V. Maino, A. Landay, C. Rinaldo, L. Jacobson, L. Montaner (2007)
Early and delayed benefits of HIV-1 suppression: timeline of recovery of innate immunity effector cellsAIDS, 21
Jiyuan Zhang, Zheng Zhang, Xi-cheng Wang, Jun‐liang Fu, Jin-xia Yao, Y. Jiao, Liang-en Chen, Hui Zhang, Jianan Wei, Lei Jin, M. Shi, G. Gao, Hao Wu, Fu-Sheng Wang (2007)
PD-1 up-regulation is correlated with HIV-specific memory CD8+ T-cell exhaustion in typical progressors but not in long-term nonprogressors.Blood, 109 11
F. Groot, Toni Capel, M. Kapsenberg, B. Berkhout, E. Jong (2006)
Opposing roles of blood myeloid and plasmacytoid dendritic cells in HIV-1 infection of T cells: transmission facilitation versus replication inhibition.Blood, 108 6
Muhlbauer (2006)
PD-L1 is induced in hepatocytes by viral infection and by interferon-alpha and -gamma and mediates T cell apoptosisJ. Hepatol., 45
Shawn Blackburn, E. Wherry (2007)
IL-10, T cell exhaustion and viral persistence.Trends in microbiology, 15 4
Marcus Mühlbauer, M. Fleck, C. Schütz, T. Weiss, M. Froh, C. Blank, J. Schölmerich, C. Hellerbrand (2006)
PD-L1 is induced in hepatocytes by viral infection and by interferon-α and -γ and mediates T cell apoptosisZeitschrift Fur Gastroenterologie, 44
J. Chehimi, D. Campbell, L. Azzoni, D. Bacheller, E. Papasavvas, Ghassen Jerandi, K. Mounzer, J. Kostman, G. Trinchieri, L. Montaner (2002)
Persistent Decreases in Blood Plasmacytoid Dendritic Cell Number and Function Despite Effective Highly Active Antiretroviral Therapy and Increased Blood Myeloid Dendritic Cells in HIV-Infected Individuals1The Journal of Immunology, 168
H. Donaghy, A. Pozniak, B. Gazzard, N. Qazi, J. Gilmour, F. Gotch, S. Patterson (2001)
Loss of blood CD11c(+) myeloid and CD11c(-) plasmacytoid dendritic cells in patients with HIV-1 infection correlates with HIV-1 RNA virus load.Blood, 98 8
C. Petrovas, J. Casazza, J. Brenchley, D. Price, E. Gostick, W. Adams, M. Precopio, T. Schacker, M. Roederer, D. Douek, R. Koup (2006)
PD-1 is a regulator of virus-specific CD8+ T cell survival in HIV infectionThe Journal of Experimental Medicine, 203
M. Barron, N. Blyveis, B. Palmer, S. MaWhinney, Cara Wilson (2003)
Influence of plasma viremia on defects in number and immunophenotype of blood dendritic cell subsets in human immunodeficiency virus 1-infected individuals.The Journal of infectious diseases, 187 1
C. Boni, P. Fisicaro, C. Valdatta, B. Amadei, Paola Vincenzo, T. Giuberti, D. Laccabue, A. Zerbini, A. Cavalli, G. Missale, A. Bertoletti, C. Ferrari (2007)
Characterization of Hepatitis B Virus (HBV)-Specific T-Cell Dysfunction in Chronic HBV InfectionJournal of Virology, 81
G. Rosignoli, Alison Cranage, C. Burton, M. Nelson, A. Steel, B. Gazzard, F. Gotch, N. Imami (2007)
Expression of PD-L1, a marker of disease status, is not reduced by HAART in aviraemic patientsAIDS, 21
C. Servet, Laurence Zitvogel, A. Hosmalin (2002)
Dendritic cells in innate immune responses against HIV.Current molecular medicine, 2 8
Z. Grossman, Martin Meier-Schellersheim, W. Paul, L. Picker (2006)
Pathogenesis of HIV infection: what the virus spares is as important as what it destroysNature Medicine, 12
N. Schmitt, M. Nugeyre, D. Scott‐Algara, M. Cumont, F. Barré-Sinoussi, G. Pancino, N. Israël (2006)
Differential susceptibility of human thymic dendritic cell subsets to X4 and R5 HIV-1 infectionAIDS, 20
T. Curiel, Shuang Wei, Haidong Dong, Xavier Alvarez, P. Cheng, P. Mottram, R. Krzysiek, K. Knutson, B. Daniel, M. Zimmermann, O. David, M. Burow, Alan Gordon, N. Dhurandhar, L. Myers, R. Berggren, A. Hemminki, R. Alvarez, D. Émilie, D. Curiel, Lieping Chen, W. Zou (2003)
Blockade of B7-H1 improves myeloid dendritic cell–mediated antitumor immunityNature Medicine, 9
Daniel Barber, E. Wherry, D. Masopust, Baogong Zhu, James Allison, Arlene Sharpe, Gordon Freeman, R. Ahmed (2006)
Restoring function in exhausted CD8 T cells during chronic viral infectionNature, 439
S. Urbani, B. Amadei, D. Tola, M. Massari, S. Schivazappa, G. Missale, C. Ferrari (2006)
PD-1 Expression in Acute Hepatitis C Virus (HCV) Infection Is Associated with HCV-Specific CD8 ExhaustionJournal of Virology, 80
B. Schmidt, S. Fujimura, Jeffrey Martin, J. Levy (2006)
Variations in Plasmacytoid Dendritic Cell (PDC) and Myeloid Dendritic Cell (MDC) Levels in HIV-Infected Subjects on and off Antiretroviral TherapyJournal of Clinical Immunology, 26
L. Golden‐Mason, B. Palmer, J. Klarquist, J. Mengshol, Nicole Castelblanco, H. Rosen (2007)
Upregulation of PD-1 Expression on Circulating and Intrahepatic Hepatitis C Virus-Specific CD8+ T Cells Associated with Reversible Immune DysfunctionJournal of Virology, 81
K. Loré, A. Smed-Sörensen, J. Vasudevan, J. Mascola, R. Koup (2005)
Myeloid and plasmacytoid dendritic cells transfer HIV-1 preferentially to antigen-specific CD4+ T cellsThe Journal of Experimental Medicine, 201
D. Anthony, Nicole Yonkers, A. Post, R. Asaad, F. Heinzel, M. Lederman, P. Lehmann, H. Valdez (2004)
Selective Impairments in Dendritic Cell-Associated Function Distinguish Hepatitis C Virus and HIV Infection1The Journal of Immunology, 172
L. Trautmann, L. Janbazian, N. Chomont, E. Said, S. Gimmig, B. Bessette, M. Boulassel, E. Delwart, H. Sepulveda, R. Balderas, J. Routy, E. Haddad, R. Sékaly (2006)
Upregulation of PD-1 expression on HIV-specific CD8+ T cells leads to reversible immune dysfunctionNature Medicine, 12
I. Pachiadakis, G. Pollara, B. Chain, N. Naoumov (2005)
Is hepatitis C virus infection of dendritic cells a mechanism facilitating viral persistence?The Lancet. Infectious diseases, 5 5
D. Trabattoni, Monica Schenal, M. Cesari, E. Castelletti, M. Pacei, B. Goldberg, A. Gori, M. Clerici (2006)
Low interleukin-10 production is associated with diabetes in HIV-infected patients undergoing antiviral therapyMedical Microbiology and Immunology, 195
H. Kuipers, Femke Muskens, M. Willart, D. Hijdra, Friso Assema, A. Coyle, H. Hoogsteden, B. Lambrecht (2006)
Contribution of the PD‐1 ligands/PD‐1 signaling pathway to dendritic cell‐mediated CD4+ T cell activationEuropean Journal of Immunology, 36
P. Cameron, A. Handley, Dean Baylis, A. Solomon, N. Bernard, D. Purcell, S. Lewin (2006)
Preferential Infection of Dendritic Cells during Human Immunodeficiency Virus Type 1 Infection of Blood LeukocytesJournal of Virology, 81
Haidong Dong, Xianming Chen (2006)
Immunoregulatory role of B7-H1 in chronicity of inflammatory responses.Cellular & molecular immunology, 3 3
D. Trabattoni, M. Saresella, M. Biasin, A. Boasso, L. Piacentini, P. Ferrante, Haidong Dong, R. Maserati, G. Shearer, Lieping Chen, M. Clerici (2003)
B7-H1 is up-regulated in HIV infection and is a novel surrogate marker of disease progression.Blood, 101 7
L. Geng, G. Jiang, Y. Fang, S. Dong, H. Xie, Y. Chen, M. Shen, S. Zheng (2006)
B7‐H1 expression is upregulated in peripheral blood CD14+ monocytes of patients with chronic hepatitis B virus infection, which correlates with higher serum IL‐10 levelsJournal of Viral Hepatitis, 13
D. Brooks, M. Trifilo, K. Edelmann, L. Teyton, D. McGavern, M. Oldstone (2006)
Interleukin-10 determines viral clearance or persistence in vivoNature Medicine, 12
Lieping Chen (2004)
Co-inhibitory molecules of the B7–CD28 family in the control of T-cell immunityNature Reviews Immunology, 4
C. Day, D. Kaufmann, P. Kiepiela, Julia Brown, Eshia Moodley, S. Reddy, Elizabeth Mackey, Joseph Miller, A. Leslie, Chantal DePierres, Z. Mncube, Jaikumar Duraiswamy, Baogong Zhu, Q. Eichbaum, M. Altfeld, E. Wherry, H. Coovadia, P. Goulder, P. Goulder, P. Goulder, P. Klenerman, R. Ahmed, G. Freeman, B. Walker, B. Walker, B. Walker (2006)
PD-1 expression on HIV-specific T cells is associated with T-cell exhaustion and disease progressionNature, 443
J. Banchereau, R. Steinman (1998)
Dendritic cells and the control of immunityNature, 392
Zheng Zhang, Jun‐liang Fu, Qing-xia Zhao, Yun He, Lei Jin, Hui Zhang, Jin-xia Yao, Linqi Zhang, Fu-Sheng Wang (2006)
Differential Restoration of Myeloid and Plasmacytoid Dendritic Cells in HIV-1-Infected Children after Treatment with Highly Active Antiretroviral Therapy1The Journal of Immunology, 176
S. Deeks, B. Walker (2007)
Human immunodeficiency virus controllers: mechanisms of durable virus control in the absence of antiretroviral therapy.Immunity, 27 3
Mette Ejrnaes, Christophe Filippi, Marianne Martinic, Eleanor Ling, Lisa Togher, S. Crotty, M. Herrath (2006)
Resolution of a chronic viral infection after interleukin-10 receptor blockadeThe Journal of Experimental Medicine, 203
A. Smed-Sörensen, K. Loré, J. Vasudevan, M. Louder, J. Andersson, J. Mascola, A. Spetz, R. Koup (2005)
Differential Susceptibility to Human Immunodeficiency Virus Type 1 Infection of Myeloid and Plasmacytoid Dendritic CellsJournal of Virology, 79
A. O’Garra, P. Vieira (2007)
TH1 cells control themselves by producing interleukin-10Nature Reviews Immunology, 7
Cheng Chen, Qiu-Xia Qu, Jian-an Huang, Yi-bei Zhu, Y. Ge, Qin Wang, Xue-guang Zhang (2007)
Expression of programmed-death receptor ligands 1 and 2 may contribute to the poor stimulatory potential of murine immature dendritic cells.Immunobiology, 212 3
Liang-en Chen, Zheng Zhang, Weiwei Chen, Zhidong Zhang, Yonggang Li, M. Shi, Jiyuan Zhang, Lieping Chen, Shengdian Wang, Fu-Sheng Wang (2007)
B7-H1 Up-Regulation on Myeloid Dendritic Cells Significantly Suppresses T Cell Immune Function in Patients with Chronic Hepatitis B1The Journal of Immunology, 178
Julia Brown, D. Dorfman, F. Ma, Elizabeth Sullivan, O. Muñoz, C. Wood, E. Greenfield, G. Freeman (2003)
Blockade of Programmed Death-1 Ligands on Dendritic Cells Enhances T Cell Activation and Cytokine Production 1The Journal of Immunology, 170
Yong‐jun Liu (2005)
IPC: professional type 1 interferon-producing cells and plasmacytoid dendritic cell precursors.Annual review of immunology, 23
Impaired myeloid dendritic cells (mDC) fail to elicit host antiviral immune responses, leading to disease progression in HIV‐1 infection. However, mechanisms underlying mDC suppression remain elusive. In this study, we found that the T‐cell co‐stimulatory molecule programmed death‐1 ligand‐1 (B7‐H1) is significantly up‐regulated on peripheral mDC in HIV‐1‐infected typical progressors and AIDS patients, but is maintained at a relatively low level in long‐term non‐progressors. Successful immune reconstitution after highly active antiretroviral therapy, indicated by full suppression of HIV‐1 replication and substantial increases of CD4 T‐cell counts, correlated with a decrease in B7‐H1 expression. Importantly, we also found that X4 HIV‐1 isolates directly induced B7‐H1 expression on mDC in vitro, while adding antiviral agents hampered this B7‐H1 up‐regulation. Blockade of B7‐H1 in vitro strongly enhanced mDC‐mediated allostimulatory capacity and IL‐12 production. In contrast, B7‐H1 ligation with soluble programmed death‐1 (PD‐1) reduced mDC maturation and IL‐12 production but increased mDC apoptosis and IL‐10 production. Thus, B7‐H1 up‐regulation may inhibit mDC‐mediated immune response, thereby facilitating viral persistence and disease progression in HIV‐1‐infected patients. This study provides new evidence that B7‐H1 inhibitory signaling may reversely mediate functional impairment of mDC in HIV‐1 infection, which further supports the notion that B7‐H1 blockade represents a novel therapeutic approach to this disease.
European Journal of Immunology – Wiley
Published: Nov 1, 2008
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.